Skip to content

Fertiga: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Fertiga

BE 0680.559.621
NACE 72.101, Research and development on biotechnology
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€209,845
2024 · -€289,381+€79,536
Equity
€2.0m
2024 · -€194,974+€2.2m
Cash
€745,955
2024 · €1.6m-€866,881
Balance sheet total
€2.1m
2024 · €2.1m-€39,620

Largest movements

2024 to 2025
Assets
  • Cash -€866,881

    down €866,881 (-53.7%), from €1.6m to €745,955

    mainly Debts after one year (-€2.0m) and Current investments (-€500,000)

  • Current investments +€500,000

    new in 2025: €500,000

  • Intangible fixed assets +€330,965

    up €330,965 (+80.6%), from €410,825 to €741,790

Equity and liabilities
  • Contributions +€2.3m

    up €2.3m (+126%), from €1.8m to €4.1m

    of which Contributions outside capital: +€2.2m

  • Debts after one year -€2.0m

    down €2.0m (-100%), from €2.0m to €0

  • Profit (loss) carried forward -€209,845

    down €209,845 (-9.4%), from -€2.2m to -€2.4m

  • Accrued charges and deferred income -€209,096

    down €209,096 (-100%), from €209,096 to €0

  • Investment grants +€103,354

    up €103,354 (+44.5%), from €232,234 to €335,588

Income statement
  • Financial charges -€147,045

    down €147,045 (-70.2%), from €209,588 to €62,543

  • Gross operating margin -€82,637

    down €82,637 (-45.6%), from €181,115 to €98,477

  • Depreciation +€75,361

    up €75,361 (+307%), from €24,548 to €99,909

  • Financial income +€50,821

    up €50,821 (+5,159%), from €985 to €51,807

  • Staff costs -€39,535

    down €39,535 (-16.7%), from €236,245 to €196,709

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€289,381
Gross operating margin -€82,637
Staff costs +€39,535
Depreciation -€75,361
Other operating charges +€133
Financial income +€50,821
Financial charges +€147,045
Result 2025 -€209,845
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€322,674
Investment -€918,896
Financing +€374,689
Cash 2024 €1.6m
Net result for the year -€209,845
Depreciation +€99,909
Smaller working-capital items -€7,713
Trade debts +€11,881
Tax, wage and social debts -€7,809
Accrued charges and deferred income -€209,096
Investment in fixed assets (net) -€418,896
Current investments -€500,000
Debts after one year -€2.0m
Contributions, distributions and other +€2.4m
Cash 2025 €745,955
brings cash intakes cash out
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €2,097,412 €2,057,793 -€39,620 -1.9%
Formation expenses 20 €0 - =
Fixed assets 21/28 €441,465 €760,452 +€318,987 +72.3%
Intangible fixed assets 21 €410,825 €741,790 +€330,965 +80.6%
Tangible fixed assets 22/27 €30,640 €18,662 -€11,978 -39.1%
Plant, machinery and equipment 23 €30,640 €18,662 -€11,978 -39.1%
Current assets 29/58 €1,655,947 €1,297,340 -€358,607 -21.7%
Stocks and contracts in progress 3 €22,197 €23,365 +€1,168 +5.3%
Stocks 30/36 €22,197 €23,365 +€1,168 +5.3%
Amounts receivable within one year 40/41 €16,674 €22,329 +€5,655 +33.9%
Trade receivables 40 €690 €0 -€690 -100%
Other amounts receivable 41 €15,984 €22,329 +€6,345 +39.7%
Current investments 50/53 - €500,000 +€500,000
Cash at bank and in hand 54/58 €1,612,836 €745,955 -€866,881 -53.7%
Deferred charges and accrued income 490/1 €4,240 €5,692 +€1,452 +34.2%
Total equity and liabilities 10/49 €2,097,412 €2,057,793 -€39,620 -1.9%
Equity 10/15 -€194,974 €1,969,869 +€2.2m
Contributions 10/11 €1,798,941 €4,070,276 +€2.3m +126%
Capital 10 €114,250 €140,200 +€25,950 +22.7%
Issued capital 100 €114,250 €140,200 +€25,950 +22.7%
Contributions outside capital 11 €1,684,691 €3,930,076 +€2.2m +133%
Share premium 1100/10 €1,684,691 €3,930,076 +€2.2m +133%
Profit (loss) carried forward 14 -€2,226,149 -€2,435,994 -€209,845 -9.4%
Investment grants 15 €232,234 €335,588 +€103,354 +44.5%
Amounts payable 17/49 €2,292,387 €87,923 -€2.2m -96.2%
Amounts payable after more than one year 17 €2,000,000 €0 -€2.0m -100%
Financial debts 170/4 €2,000,000 €0 -€2.0m -100%
Amounts payable within one year 42/48 €83,291 €87,923 +€4,632 +5.6%
Trade debts 44 €38,438 €50,319 +€11,881 +30.9%
Suppliers 440/4 €38,438 €50,319 +€11,881 +30.9%
Taxes, remuneration and social security 45 €44,631 €36,822 -€7,809 -17.5%
Remuneration and social security 454/9 €44,631 €36,822 -€7,809 -17.5%
Other amounts payable 47/48 €222 €782 +€561 +253%
Accrued charges and deferred income 492/3 €209,096 €0 -€209,096 -100%
Remuneration, social security and pensions 62 €236,245 €196,709 -€39,535 -16.7%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €24,548 €99,909 +€75,361 +307%
Other operating charges 640/8 €1,101 €968 -€133 -12.1%
Gross operating margin 9900 €181,115 €98,477 -€82,637 -45.6%
Operating profit (loss) 9901 -€80,779 -€199,109 -€118,330 -146%
Financial income 75/76B €985 €51,807 +€50,821 +5,159%
Recurring financial income 75 €985 €51,807 +€50,821 +5,159%
Financial charges 65/66B €209,588 €62,543 -€147,045 -70.2%
Recurring financial charges 65 €209,588 €62,543 -€147,045 -70.2%
Profit (loss) for the period before taxes 9903 -€289,381 -€209,845 +€79,536 +27.5%
Profit (loss) for the period 9904 -€289,381 -€209,845 +€79,536 +27.5%
Profit (loss) for the period to be appropriated 9905 -€289,381 -€209,845 +€79,536 +27.5%

Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 18 October 2026 via checked.be.